View source

{{Infobox_Institution
|myInstitutionname=University of Oxford - Fredrik Karpe, Oxford Laboratory for Integrative Physiology (OXLIP), Oxford Center for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford
|myLogo=
|myCountry=United Kingdoms
|myBenefitnr=P22
|myAbout=
|myContribution=The Karpe lab brings extensive experience in the study of type 2 diabetes, insulin resistance and metabolic syndrome in human cohorts. The experience in clinical trials and Biobanks including the use of stable isotopes will benefit LipidomicNet, whilst access to existing samples together with new patients will be of particular importance.
|myTaskforces=
|myWorkpackages=
}}